Pathologic Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB11714 | Durvalumab | 1 / 2 | Terminated | 1 |
| DB11771 | Tremelimumab | 1 / 2 | Terminated | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Recruiting | 1 |
| DB14547 | Chloride ion | 2 / 3 | Suspended | 1 |
| DB00515 | Cisplatin | 2 / 3 | Suspended | 1 |
| DB09035 | Nivolumab | 2 / 3 | Suspended | 1 |
| DB12257 | Platinum | 2 / 3 | Suspended | 1 |